On October 31, 2025, Lunai Bioworks Inc. held its annual meeting where shareholders approved the election of four directors, the compensation of executives, the appointment of an independent auditor, and amendments to the 2023 Equity Incentive Plan. The approvals included 7,539,245 votes for David Weinstein and 8,836,759 votes for the auditor Sadler, reflecting positive shareholder support.